C07H 19/20
With the saccharide radical esterified by phosphoric or polyphosphoric acids
Official title: with the saccharide radical esterified by phosphoric or polyphosphoric acids
C07H19/20 (With the saccharide radical esterified by phosphoric or polyphosphoric acids) appears on 1,536 US grants and 1,462 published applications in this corpus.
Search patents in C07H- Granted patents
- 1,536
- Published applications
- 1,462
- Assignees
- 647
- Inventors
- 2,861
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 6 | 0 |
| 1977 | 12 | 0 |
| 1978 | 3 | 0 |
| 1979 | 13 | 0 |
| 1980 | 5 | 0 |
| 1981 | 5 | 0 |
| 1982 | 4 | 0 |
| 1983 | 9 | 0 |
| 1984 | 6 | 0 |
| 1985 | 7 | 0 |
| 1986 | 7 | 0 |
| 1987 | 10 | 0 |
| 1988 | 6 | 0 |
| 1989 | 14 | 0 |
| 1990 | 6 | 0 |
| 1991 | 11 | 0 |
| 1992 | 12 | 0 |
| 1993 | 16 | 0 |
| 1994 | 14 | 0 |
| 1995 | 21 | 0 |
| 1996 | 36 | 0 |
| 1997 | 60 | 0 |
| 1998 | 63 | 0 |
| 1999 | 60 | 0 |
| 2000 | 38 | 0 |
| 2001 | 49 | 19 |
| 2002 | 37 | 45 |
| 2003 | 41 | 83 |
| 2004 | 32 | 74 |
| 2005 | 32 | 47 |
| 2006 | 56 | 43 |
| 2007 | 32 | 49 |
| 2008 | 34 | 25 |
| 2009 | 33 | 50 |
| 2010 | 32 | 66 |
| 2011 | 32 | 50 |
| 2012 | 38 | 51 |
| 2013 | 44 | 61 |
| 2014 | 50 | 75 |
| 2015 | 52 | 56 |
| 2016 | 58 | 70 |
| 2017 | 42 | 56 |
| 2018 | 42 | 58 |
| 2019 | 53 | 84 |
| 2020 | 54 | 67 |
| 2021 | 65 | 69 |
| 2022 | 37 | 54 |
| 2023 | 44 | 74 |
| 2024 | 43 | 64 |
| 2025 | 39 | 41 |
| 2026 | 21 | 31 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Artificial nucleic acid, method for producing same, and use thereof22 Sep 2026US 12,741,983 B2Riken Genesis Co., Ltd.
- Nucleotide hemi-sulfate salt for the treatment of hepatitis C virus22 Sep 2026US 12,741,984 B2Atea Pharmaceuticals, Inc.
- Chiral synthons for the synthesis of chiral phosphorothioates25 Aug 2026US 12,715,885 B2Boehringer Ingelheim International GmbH
- Nucleoside analogs and use thereof in therapeutic treatment4 Aug 2026US 12,698,305 B2Cornell University
- Advantageous morphic form of AT-527 hemi-sulfate salt21 Jul 2026US 12,686,697 B2Atea Pharmaceuticals, Inc.
- Substituted bicyclic heterocycle compounds, compositions, and uses thereof1 Oct 2026US 2026/0294949 A1
- Adenosine analog and its use in regulating the circadian clock1 Oct 2026US 2026/0294952 A1National Institute of Biological Sciences, Beijing
- Design and synthesis of novel disulfide linker based nucleotides as reversible terminators for dna sequencing by synthesis1 Oct 2026US 2026/0297664 A1The Trustees of Columbia University in the City of New York
- Process for extraction of adenosine triphosphate (atp) from plant material17 Sep 2026US 2026/0274884 A1
- Crystalline monomers for preparing antisense oligonucleotides and methods of their preparation and use3 Sep 2026US 2026/0258063 A1Eisai R&D Management Co., Ltd.
Most cited
By later US patents
- Labelled nucleotides1,103US 7,057,026 B2Solexa Limited · 2006
- N-2 substituted purines806US 5,459,255 AIsis Pharmaceuticals, Inc. · 1995
- Modified nucleotides and methods of preparing and using same734US 4,711,955 AYale University · 1987
- Oligonucleotides containing 5-propynyl pyrimidines670US 5,484,908 AGilead Sciences, Inc. · 1996
- Sugar modified oligonucleotides that detect and modulate gene expression641US 5,670,633 AIsis Pharmaceuticals, Inc. · 1997